Silo Pharma partners on intranasal PTSD treatment for FDA review
Silo Pharma, a biopharmaceutical company listed on NASDAQ (SILO), has announced a partnership with Resyca BV, a medical technology provider,…
Silo Pharma, a biopharmaceutical company listed on NASDAQ (SILO), has announced a partnership with Resyca BV, a medical technology provider,…
The Eating Disorders Service focuses on providing specialized treatment for individuals facing challenges with eating disorders, including anorexia nervosa, bulimia…
The transition to motherhood can be a joyful experience, yet many new mothers face challenges, including postpartum depression (PPD). Recent…
Beckley Psytech, a UK-based developer of psychedelic medications, has announced positive findings from its phase 2 trial of BPL-003, a…
Depression can feel like an unwelcome presence that lingers despite treatment efforts. For approximately 30% of individuals battling depression, traditional…
Researchers at Massachusetts General Hospital have created a machine learning model that identifies women at high risk for postpartum depression…
Cannabis has gained attention for its potential to stimulate appetite, particularly in individuals facing serious medical conditions like cancer and…
Postpartum depression (PPD) affects approximately 13% of new mothers, leading to significant emotional distress and difficulties in bonding with their…
Mental health conditions affect millions globally, yet misconceptions persist, portraying individuals with mental illness as dangerous or weak. These stereotypes…
Researchers at the Icahn School of Medicine at Mount Sinai have discovered a new mechanism for treating major depressive disorder…